메뉴 건너뛰기




Volumn 26, Issue 1, 2015, Pages 7-12

Randomized clinical trial of the efficacy of dentifrices containing 1.5% Arginine, an insoluble calcium compound and 1450 ppm fluoride over two years

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALCIUM CARBONATE; CALCIUM PHOSPHATE; FLUORIDE; FLUOROPHOSPHATE; PHOSPHATE; SODIUM FLUORIDE; TOOTHPASTE;

EID: 84931840004     PISSN: 08958831     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (30)

References (28)
  • 3
    • 84931861412 scopus 로고    scopus 로고
    • Retrieved December 10, 2014
    • Healthy People 2020. http://www.healthypeople.gov/2020/topics-objectives/topic/oral-health/objectives - Retrieved December 10, 2014
  • 5
    • 0030203380 scopus 로고    scopus 로고
    • Reasons for the caries decline: What do the experts believe?
    • Bratthall D, Hänsel-Petersson G, Sundberg H. Reasons for the caries decline: what do the experts believe? Eur J Oral Sci 1996; 104:416-22.
    • (1996) Eur J Oral Sci , vol.104 , pp. 416-422
    • Bratthall, D.1    Hänsel-Petersson, G.2    Sundberg, H.3
  • 6
    • 84883802279 scopus 로고    scopus 로고
    • st century - The exploration of a breakthrough technology for caries prevention
    • st century - the exploration of a breakthrough technology for caries prevention. J Clin Dent 2013;24(Spec Iss A):A1-14.
    • (2013) J Clin Dent , vol.24 , pp. A1-14
    • Cummins, D.1
  • 7
    • 27344435053 scopus 로고    scopus 로고
    • The inhibitory effect of an argjnine bicarbonate/calcium carbonate cavistat-containing dentifrice on the development of dental caries in venezuelan school children
    • Acevedo AM, Machedo C, Rivera LE, Wolff M, Kleinberg I. The inhibitory effect of an argjnine bicarbonate/calcium carbonate Cavistat-containing dentifrice on the development of dental caries in Venezuelan school children. J Clin Dent 2005;16:63-70.
    • (2005) J Clin Dent , vol.16 , pp. 63-70
    • Acevedo, A.M.1    Machedo, C.2    Rivera, L.E.3    Wolff, M.4    Kleinberg, I.5
  • 8
    • 42149134878 scopus 로고    scopus 로고
    • Clinical evaluation of the ability of cavistat® in a mint confection to inhibit the development of dental caries in children
    • Acevedo AM, Montera M, Rojas-Sanchez F, Machedo C, Rivera LE, Wolff M, Kleinberg I. Clinical evaluation of the ability of Cavistat® in a mint confection to inhibit the development of dental caries in children. J Clin Dent 2008;19:1-8.
    • (2008) J Clin Dent , vol.19 , pp. 1-8
    • Acevedo, A.M.1    Montera, M.2    Rojas-Sanchez, F.3    Machedo, C.4    Rivera, L.E.5    Wolff, M.6    Kleinberg, I.7
  • 9
    • 84883824641 scopus 로고    scopus 로고
    • A clinical investigation of the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride, as sodium monofluorophosphate in a calcium base, on primary root caries
    • Hu DY, Yin W, Li X, Feng Y, Zhang YP, Cummins D, Mateo LR, Ellwood RP. A clinical investigation of the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride, as sodium monofluorophosphate in a calcium base, on primary root caries. J Clin Dent 2013;24(Spec Iss A): A23-31.
    • (2013) J Clin Dent , vol.24 , pp. A23-31
    • Hu, D.Y.1    Yin, W.2    Li, X.3    Feng, Y.4    Zhang, Y.P.5    Cummins, D.6    Mateo, L.R.7    Ellwood, R.P.8
  • 10
    • 84883810831 scopus 로고    scopus 로고
    • Comparing the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride to a dentifrice containing 1450 ppm fluoride alone in the management of primary root caries
    • Souza MLR, Cury JA, Tenuta LMA, Zhang YP, Mateo LR, Cummins D, Ellwood RP. Comparing the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride to a dentifrice containing 1450 ppm fluoride alone in the management of primary root caries. J Dent 2013;41 S:S35-41.
    • (2013) J Dent , vol.41 S , pp. S35-41
    • Souza, M.L.R.1    Cury, J.A.2    Tenuta, L.M.A.3    Zhang, Y.P.4    Mateo, L.R.5    Cummins, D.6    Ellwood, R.P.7
  • 11
    • 84883799198 scopus 로고    scopus 로고
    • Comparison of the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride to a dentifrice containing 1450 ppm fluoride alone in the management of early coronal caries as assessed using quantitative light-induced fluorescence
    • Srisilapanan P, Korwanich N, Yin W, Chuensuwonkul C, Mateo LR, Zhang YP, Cummins D, Ellwood RP. Comparison of the efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride to a dentifrice containing 1450 ppm fluoride alone in the management of early coronal caries as assessed using Quantitative Light-induced Fluorescence. J Dent 2013;41S:S29-34.
    • (2013) J Dent , vol.41 S , pp. S29-34
    • Srisilapanan, P.1    Korwanich, N.2    Yin, W.3    Chuensuwonkul, C.4    Mateo, L.R.5    Zhang, Y.P.6    Cummins, D.7    Ellwood, R.P.8
  • 12
    • 84883756911 scopus 로고    scopus 로고
    • A clinical investigation using quantitative light-induced fluorescence (QLF) of the anticaries efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate
    • Yin W, Hu DY, Fan X, Feng Y, Zhang YP, Cummins D, Mateo LR, Pretty IA, Ellwood RP. A clinical investigation using quantitative light-induced fluorescence (QLF) of the anticaries efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate. J Clin Dent 2013;24(Spec Iss A):A15-22.
    • (2013) J Clin Dent , vol.24 , pp. A15-22
    • Yin, W.1    Hu, D.Y.2    Fan, X.3    Feng, Y.4    Zhang, Y.P.5    Cummins, D.6    Mateo, L.R.7    Pretty, I.A.8    Ellwood, R.P.9
  • 13
    • 84883778065 scopus 로고    scopus 로고
    • The anti-caries efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate assessed using quantitative light-induced fluorescence (QLF)
    • Yin W, Hu DY, Li X, Fan X, Zhang YP, Pretty IA, Mateo LR, Cummins D, Ellwood RP The anti-caries efficacy of a dentifrice containing 1.5% arginine and 1450 ppm fluoride as sodium monofluorophosphate assessed using Quantitative Light-induced Fluorescence (QLF). J Dent 2013;41S:S22-8.
    • (2013) J Dent , vol.41 S , pp. S22-8
    • Yin, W.1    Hu, D.Y.2    Li, X.3    Fan, X.4    Zhang, Y.P.5    Pretty, I.A.6    Mateo, L.R.7    Cummins, D.8    Ellwood, R.P.9
  • 14
    • 84883824053 scopus 로고    scopus 로고
    • Two-year caries clinical study of the efficacy of novel dentifrices containing 1.5% arginine, an insoluble calcium compound and 1, 450 ppm fluoride
    • Kraivaphan P, Amornchat C, Triratana T, Mateo LR, Ellwood R, Cummins D, DeVizio W, Zhang YP. Two-year caries clinical study of the efficacy of novel dentifrices containing 1.5% arginine, an insoluble calcium compound and 1, 450 ppm fluoride, Caries Res 2013;47:582-90.
    • (2013) Caries Res , vol.47 , pp. 582-590
    • Kraivaphan, P.1    Amornchat, C.2    Triratana, T.3    Mateo, L.R.4    Ellwood, R.5    Cummins, D.6    DeVizio, W.7    Zhang, Y.P.8
  • 15
    • 84883784079 scopus 로고    scopus 로고
    • In situ clinical effects of new dentifrices containing 1.5% arginine and 1450 ppm fluoride on enamel de- and remineralization and plaque metabolism
    • Cantore R, Petrou I, Lavender S, Santarpia P, Liu Z, Vandeven M, Cummins D, Sullivan R, Utgikar N. In situ clinical effects of new dentifrices containing 1.5% arginine and 1450 ppm fluoride on enamel de- and remineralization and plaque metabolism, J Clin Dent 2013;24(Spec Iss A):A32-44.
    • (2013) J Clin Dent , vol.24 , pp. A32-44
    • Cantore, R.1    Petrou, I.2    Lavender, S.3    Santarpia, P.4    Liu, Z.5    Vandeven, M.6    Cummins, D.7    Sullivan, R.8    Utgikar, N.9
  • 17
    • 84902011150 scopus 로고    scopus 로고
    • A 12-week clinical study assessing the clinical effects on plaque metabolism of a dentifrice containing 1.5% arginine, an insoluble calcium compound and 1, 450 ppm fluoride
    • Santarpia III RP, Lavender S, Gittins E, Vandeven M, Cummins D, Sullivan R. A 12-week clinical study assessing the clinical effects on plaque metabolism of a dentifrice containing 1.5% arginine, an insoluble calcium compound and 1, 450 ppm fluoride Am J Dent 2014;27:100-5.
    • (2014) Am J Dent , vol.27 , pp. 100-105
    • Santarpia, R.P.1    Lavender, S.2    Gittins, E.3    Vandeven, M.4    Cummins, D.5    Sullivan, R.6
  • 19
    • 0015754757 scopus 로고
    • Principal requirements for controlled clinical trials of caries preventive agents and procedures
    • Horowitz HS, Baume LJ, Dirks OB, Davies GN, Stack GL Principal requirements for controlled clinical trials of caries preventive agents and procedures. Int Dent J 1973;23:506-16.
    • (1973) Int Dent J , vol.23 , pp. 506-516
    • Horowitz, H.S.1    Baume, L.J.2    Dirks, O.B.3    Davies, G.N.4    Stack, G.L.5
  • 23
    • 0024097701 scopus 로고
    • Report of workshop aimed at defining guidelines for caries clinical trials: Superiority and equivalency claims for anticaries dentifrices
    • American Dental Association Council on Dental Therapeutics (ADA): Report of workshop aimed at defining guidelines for caries clinical trials: superiority and equivalency claims for anticaries dentifrices, J Am Dent Assoc 1988;117: 663-5.
    • (1988) J Am Dent Assoc , vol.117 , pp. 663-665
    • American Dental Association Council on Dental Therapeutics (ADA)1
  • 24
    • 0029447408 scopus 로고
    • Comparative attribute for the description of the relative efficacy of therapeutic agents: General concepts and definitions, and application to the American dental association guidelines for the comparison of the clinical anticaries efficacy of fluoride dentifrices
    • Proskin HM, Kingman A, Naleway C, and Wozniak W: Comparative attribute for the description of the relative efficacy of therapeutic agents: general concepts and definitions, and application to the American Dental Association Guidelines for the comparison of the clinical anticaries efficacy of fluoride dentifrices. J Clin Dent 1995;6:176-84.
    • (1995) J Clin Dent , vol.6 , pp. 176-184
    • Proskin, H.M.1    Kingman, A.2    Naleway, C.3    Wozniak, W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.